Obesity

Biotech Elaine Chen

STAT Plus: Structure Therapeutics oral GLP-1 drug led to weight loss in two studies

Health Elizabeth Cooney

Study finds BMI, despite flaws, is useful estimate of body fat in children

Special Report Anissa Durham

New obesity drugs are seemingly everywhere. Black Americans feel left out

Special Report Anissa Durham

Black voices, Black bodies: Life in the age of Ozempic

Health Elizabeth Cooney

Reversing progress, stroke rates are rising, especially in working-age adults

Biotech Allison DeAngelis and Elaine Chen

STAT Plus: Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy

First Opinion Jenna Phillips

What clinical real-world data can deliver

The Readout LOUD Allison DeAngelis and Adam Feuerstein

STAT Plus: Listen: Live! From the STAT Breakthrough Summit West

Pharma Andrew Joseph

STAT Plus: Obesity drug from Roche succeeds in early test, sending company shares up

Pharma Isabella Cueto and Elaine Chen

STAT Plus: Novo to test Wegovy and other obesity drugs against alcohol-related liver disease

Biotech Elaine Chen

STAT Plus: 4 burning questions about Amgen’s obesity drug, a potential Wegovy and Zepbound competitor

The Readout LOUD Adam Feuerstein and Allison DeAngelis

STAT Plus: Listen: Controversial brain tissue research, obesity drug sales, and Novartis’ M&A drama

Biotech Elaine Chen

STAT Plus: Novo Nordisk defends Ozempic’s price in face of Senate scrutiny

Biotech Elaine Chen

STAT Plus: Eli Lilly raises earnings guidance as it ramps up Mounjaro, Zepbound manufacturing

The Readout Elaine Chen

STAT Plus: Bernie Sanders targets ‘outrageously high price’ of Ozempic

Health Elizabeth Cooney

Decline in heart failure deaths has been undone, led by people under 45

The Readout Elaine Chen

STAT Plus: A spending frenzy on obesity drugs

Biotech Elaine Chen

STAT Plus: New studies suggest GLP-1 health care costs have only begun to climb

First Opinion Jonathan Isaacsohn

Moving the conversation about obesity beyond the scale

The Readout LOUD Allison DeAngelis and Adam Feuerstein

STAT Plus: Listen: A new obesity startup, an acquisition gone wrong, & the future of Teladoc

Biotech Allison DeAngelis

STAT Plus: ARCH, Medicines Co. veterans raise $290 million for in-licensed obesity drugs

Biotech Elaine Chen

STAT Plus: Eli Lilly’s Zepbound eases obstructive sleep apnea in trials

Health Andrew Joseph

European regulators find no evidence of link between new obesity medicines and suicidal thoughts

Pharma Elaine Chen

STAT Plus: Positive trial results set up obesity drug Wegovy for use against heart failure

First Opinion Patrick Skerrett

STAT readers on biotech and national security, liquid-only diets before colonoscopy, and the value of weight loss drugs

Biotech Elaine Chen

STAT Plus: Parkinson’s disease may be helped by GLP-1 drug, new study finds

First Opinion Dana P. Goldman and Alison Sexton Ward

Medicare coverage of weight loss drugs could save the U.S. billions of dollars

Health Elaine Chen

Ozempic-like drugs linked to low, but increased risk of post-endoscopy pneumonia, study finds

First Opinion Lisa Shah

Oprah kicked off a national conversation on obesity and GLP-1 drugs. Let’s have it